LUCD: Lucid Diagnostics Inc

LUCD新闻

• 11:24 Lucid Diagnostics stock holds steady as BTIG reiterates Buy rating
• 11:55 Cantor Fitzgerald reiterates Overweight rating on Lucid Diagnostics stock
• 20:39 Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript
• 13:15 Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Tops Revenue Estimates
• 12:28 Lucid Diagnostics earnings beat, revenue was in line with estimates
• 12:16 LUCD Reports Results
• 19:00 Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
• 22:55 Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates
• 13:15 Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
• 21:10 Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
• 16:12 Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics’ EsoGuard ® Esophageal DNA Test
• 10:14 Ascendiant Capital raises Lucid Diagnostics stock price target to $7.75
• 12:42 SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Algoma Steel Group (NASDAQ:ASTL), Arvinas (NASDAQ:ARVN)
• 11:33 Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes
• 11:30 Cantor Fitzgerald maintains Lucid Diagnostics stock Overweight
• 19:53 PAVmed Q1 2025 slides: net income soars amid strategic restructuring
• 21:32 Cantor maintains Lucid Diagnostics stock with $2 target after Q1 results
• 14:27 Lucid Diagnostics earnings beat by $0.03, revenue fell short of estimates
• 14:53 Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Lucid Diagnostics (NASDAQ:LUCD)
• 13:51 Lucid Diagnostics Inc. 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:LUCD)